Either Hep3B empty-vector (EV) or Cripto-1 stable-expressing clone was treated with translational inhibitor cycloheximide (CHX, Sigma) at concentration of 50 μg/mL for indicated time. Target protein expression were quantified using ImageJ, which was normalized with respective β-actin levels. Protein level remaining upon CHX treatment was plotted relative to untreated control at 0 h.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.